Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
13-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
13-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Journals
Journal #197
advertisement
Vestnik Oftalmologii
4
Showing records 1 to 4 |
Display all abstracts in
Vestnik Oftalmologii
27903
Role of secondary pathogenic factors in the pathogenesis of primary open-angle glaucoma
Lebedev OI; Stepanova EA
Vestnik Oftalmologii
2010; 126: 42-45
27904
Expression of the antimicrobial peptide beta-defensin-2 in the conjunctival epithelial cells in primary open-angle glaucoma and over time in the postoperative period
Erichev VP; Gankovskaia LV; Koval'chuk LV; Gankovskaia OA; Dugina AE
Vestnik Oftalmologii
2010; 126: 19-22
27902
Results of clinical evaluation of a new screening method for determining the individual normal level of intraocular pressure
Avetisov SE; Mamikonian VR; Kazarian OA; Shmeleva-Demir OA; Galoian NS; Mazurova IV; Tatevosian AA; Ryzhkova EG
Vestnik Oftalmologii
2010; 126: 5-7
27905
Results of combination surgical treatment for open-angle glaucoma and cataract
Mamikonian VR; Iusef IN; Vvedenskii AS; Iusef SN; Kazarian EE; Galoian NS; Tatevosian AA
Vestnik Oftalmologii
2010; 126: 3-6
Issue
13-1
Table of Contents
Editor's Selection
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept